SCHEMBL5152890

SCHEMBL5152890

[C]#CCCC(O)(CCC)C(O)CC

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5155655 0.82 TSHR (0.34) TSHR
SCHEMBL7163343 0.78 TSHR (0.31) TSHR
SCHEMBL3167182 0.74 TSHR (0.37) TSHR
SCHEMBL28468487 0.73 TSHR (0.40) TSHR
SCHEMBL5150348 0.72
SCHEMBL3160263 0.71 TSHR (0.39) TSHR
SCHEMBL3164922 0.71 TSHR (0.34) TSHR
SCHEMBL5150205 0.70 FDPS (0.31)
SCHEMBL5157639 0.69 TSHR (0.37) TSHR
SCHEMBL7164290 0.69 TSHR (0.33) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103300-B1 ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME CHUGAI PHARMACEUTICAL CO LTD (JP) 2007-01-03 EP disclosed
US-6902654-B2 Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-06-07 US disclosed
US-20040108198-A1 Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2004-06-10 US disclosed
EP-1103300-A1 ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040108198-A1 Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same VDR, GC, CYP24A1 TSHR 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.